Loading
Latest filing published 05 Dec 2025 for SELLAS Life Sciences Group, Inc., €241k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Angelos M. Stergiou, listed as chief executive, appears in our data through filings on SELLAS Life Sciences Group, Inc. shares, published by SEC (Form 4). The record holds 13 filings, for trades running from 31 December 2018 to 3 December 2025.
On the market, this insider has only sold: 3 sales, €53k in total. Outside the open market, there are 7 share grants.
On 5 December 2025 came the latest disclosure, a transaction for €241k in SELLAS Life Sciences Group, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations